Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jack Allen ...

JonesTrading analyst Soumit Roy has assigned their bullish stance on EDIT stock, giving a Buy rating today. Soumit Roy’s rating is based ...

An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.

Co-hosted by UC Santa Barbara Arts & Lectures and the Cancer Foundation of Santa Barbara, the talk will discuss CRISPR-Cas9 ...

JonesTrading analyst Debanjana Chatterjee has assigned their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...

UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...

Plunkitt of Tammany Hall,” a collection of political sermons attributed to a crooked machine boss, is a handy reference for ...

BMO Capital analyst Kostas Biliouris maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price ...

Computer scientist Geoffrey Hinton won the Nobel Prize in Physics for his work in artificial intelligence. However, he ...

The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow ...

Devleena Samanta is the first faculty member from the University of Texas at Austin to receive the early-career award in the ...

He points to the experience of Southern whites during and after slavery: having been born into a group that was perpetrating ...